U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C22H20F2N4O3
Molecular Weight 426.416
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CYCLOPROPANECARBOXAMIDE, 2-(((2,4-DIMETHYL-5-PYRIMIDINYL)OXY)METHYL)-2-(5-FLUORO-2-HYDROXYPHENYL)-N-(5-FLUORO-2-PYRIDINYL)-, (1R,2S)-

SMILES

CC1=NC=C(OC[C@]2(C[C@H]2C(=O)NC3=NC=C(F)C=C3)C4=C(O)C=CC(F)=C4)C(C)=N1

InChI

InChIKey=KSOKSTATKQAZBR-HTAPYJJXSA-N
InChI=1S/C22H20F2N4O3/c1-12-19(10-25-13(2)27-12)31-11-22(16-7-14(23)3-5-18(16)29)8-17(22)21(30)28-20-6-4-15(24)9-26-20/h3-7,9-10,17,29H,8,11H2,1-2H3,(H,26,28,30)/t17-,22+/m0/s1

HIDE SMILES / InChI

Approval Year

Name Type Language
CYCLOPROPANECARBOXAMIDE, 2-(((2,4-DIMETHYL-5-PYRIMIDINYL)OXY)METHYL)-2-(5-FLUORO-2-HYDROXYPHENYL)-N-(5-FLUORO-2-PYRIDINYL)-, (1R,2S)-
Systematic Name English
LEMBOREXANT METABOLITE M7
Common Name English
Code System Code Type Description
CAS
1369766-52-8
Created by admin on Sat Dec 16 15:31:01 GMT 2023 , Edited by admin on Sat Dec 16 15:31:01 GMT 2023
PRIMARY
PUBCHEM
56943754
Created by admin on Sat Dec 16 15:31:01 GMT 2023 , Edited by admin on Sat Dec 16 15:31:01 GMT 2023
PRIMARY
FDA UNII
16B4MW9AWJ
Created by admin on Sat Dec 16 15:31:01 GMT 2023 , Edited by admin on Sat Dec 16 15:31:01 GMT 2023
PRIMARY